A protocol for the TRACS-Liverpool study, tracking transmission of extended-spectrum beta-lactamase producing Enterobacterales across health and social care settings in the United Kingdom
Open Access
- 13 July 2026
- journal article
- Published by F1000 Research Ltd in Wellcome Open Research
- Vol. 11, 437
Abstract
Background Antimicrobial resistance (AMR) is a global public health problem. Infections caused by extended-spectrum beta-lactamase (ESBL) and carbapenemase (CP) -producing Enterobacterales (E) threaten individuals and healthcare systems worldwide. Symptomatic infection caused by Enterobacterales is typically preceded by asymptomatic colonisation and often occurs in the most vulnerable individuals, thus interrupting asymptomatic transmission is desirable. The dominant transmission routes across the healthcare continuum including hospitals, intermediate care, and long-term care facilities are not well understood. Methods Here we present a protocol describing a genomic surveillance framework developed for the Tracking Antimicrobial Resistance Across Care Settings (TRACS) Liverpool programme, which aims to identify critical ESBL-E transmission points in hospitals and care homes in Liverpool, UK. Our study integrates individual participant and healthcare facility data, validated standard operating procedures for taking and culturing stool, rectal, environmental, and staff samples, and genomic sequencing of ESBL-E, and statistical modelling approaches into a research framework for ESBL-E genomic surveillance. Discussion There is a need for improved epidemiological and laboratory approaches to studying bacterial transmission. Drug-resistant enteric bacteria are a highly tractable marker of the movement of all enteric bacteria, and interventions designed to interrupt transmission of drug-resistant bacteria are expected to have a broader healthcare impact. This protocol provides a standardised, reproducible approach for identifying ESBL-E, tracking acquisition events, and linking clinical and environmental isolates through whole-genome sequencing.Keywords
Funding Information
- Wellcome (226473)
- iiCON (Infection Innovation Consortium) via UK Research and Innovation (107136)
- Unilever (MA-2021-00523N)
This publication has 27 references indexed in Scilit:
- Health system drivers of antimicrobial resistance: a qualitative exploration of implications for infection prevention and control in hospitals and long-term care facilities in MerseysideJournal of Hospital Infection, 2025
- The WHO Bacterial Priority Pathogens List 2024: a prioritisation study to guide research, development, and public health strategies against antimicrobial resistanceThe Lancet Infectious Diseases, 2025
- Global burden of bacterial antimicrobial resistance 1990–2021: a systematic analysis with forecasts to 2050The Lancet, 2024
- SHEA/IDSA/APIC Practice Recommendation: Strategies to prevent healthcare-associated infections through hand hygiene: 2022 UpdateInfection Control & Hospital Epidemiology, 2023
- Emerging Trends of Chronic Diseases and Their Care Among Older Persons Globally2023
- Colonization dynamics of extended-spectrum beta-lactamase-producing Enterobacterales in the gut of Malawian adultsNature Microbiology, 2022
- Carbapenemase-producing Enterobacterales in hospital drains in Southern Ontario, CanadaJournal of Hospital Infection, 2020
- From Theory to Practice: Translating Whole-Genome Sequencing (WGS) into the ClinicTrends in Microbiology, 2018
- Risk of organism acquisition from prior room occupants: a systematic review and meta-analysisJournal of Hospital Infection, 2015
- Research electronic data capture (REDCap)—A metadata-driven methodology and workflow process for providing translational research informatics supportJournal of Biomedical Informatics, 2009